Education
About Us
Working with TipRanks
Follow Us
Symbio Pharmaceuticals Limited (JP:4582)
:4582
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 1.31B | ¥ 2.45B | ¥ 5.59B | ¥ 10.01B | ¥ 8.25B |
| Gross Profit | ¥ 947.34M | ¥ 1.87B | ¥ 4.41B | ¥ 7.60B | ¥ 5.80B |
| Operating Income | ¥ -4.44B | ¥ -3.88B | ¥ -811.67M | ¥ 1.96B | ¥ 1.02B |
| EBITDA | ¥ -4.60B | ¥ -3.78B | ¥ -714.00M | ¥ 2.06B | ¥ 1.11B |
| Net Income | ¥ -4.78B | ¥ -3.83B | ¥ -1.96B | ¥ 1.18B | ¥ 2.03B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 2.88B | ¥ 3.96B | ¥ 6.52B | ¥ 6.28B | ¥ 3.86B |
| Total Assets | ¥ 3.87B | ¥ 4.97B | ¥ 8.17B | ¥ 10.43B | ¥ 8.45B |
| Total Debt | ¥ 1.98B | ¥ 0.00 | ¥ 0.00 | ¥ 0.00 | ¥ 0.00 |
| Net Debt | ¥ -901.00M | ¥ -3.96B | ¥ -6.52B | ¥ -6.28B | ¥ -3.86B |
| Total Liabilities | ¥ 2.60B | ¥ 770.77M | ¥ 960.33M | ¥ 1.93B | ¥ 1.71B |
| Stockholders' Equity | ¥ 1.27B | ¥ 4.20B | ¥ 7.21B | ¥ 8.51B | ¥ 6.75B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -4.58B | ¥ -3.44B | ¥ -427.48M | ¥ 1.57B | ¥ 76.20M |
| Operating Cash Flow | ¥ -4.58B | ¥ -3.42B | ¥ -194.69M | ¥ 1.61B | ¥ 140.04M |
| Investing Cash Flow | ¥ -75.92M | ¥ -3.96M | ¥ -376.70M | ¥ -47.13M | ¥ -70.85M |
| Financing Cash Flow | ¥ 3.62B | ¥ 708.47M | ¥ 680.16M | ¥ 627.99M | ¥ -71.92M |